Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Dec. 29, 1997

CY-1503 reduces reperfusion injury in a dog lung allograft model

Dec. 22, 1997

In vitro and in vivo immunosuppressive effects of FTY-720

Dec. 22, 1997

HHS announces intention to out-license vaccine technology

Dec. 19, 1997

LJP-394 binds to B-cells in lupus patients

Dec. 17, 1997

La Jolla evaluates Toleragan compounds for xenotransplantation

Dec. 17, 1997

SmithKline Beecham licenses rotavirus vaccine

Dec. 16, 1997

Pediatric rotavirus vaccine approval recommended

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

MedImmune and SKB establish worldwide alliance for HPV vaccines

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...